Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 2:07 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 145–168 of 13,908 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control Trial Clear all

Conditions: Heart Failure, Systolic
Interventions: Autologous cell therapy, Sham; Biological · Other
Lead sponsor: BioCardia, Inc.; Industry
Eligibility: 21 Years to 90 Years
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2025
U.S. locations: 20
States / cities: Phoenix, Arizona • Los Angeles, California • Palo Alto, California + 17 more

Conditions: GERD
Interventions: Aluvra™, Saline; Device · Drug
Lead sponsor: Impleo Medical Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 10
States / cities: Los Angeles, California • Palo Alto, California • Englewood, Colorado + 7 more

Conditions: Acute Otitis Media
Interventions: Amoxicillin-Clavulanate, 10 days, Amoxicillin-Clavulanate, 5 days; Drug
Lead sponsor: Alejandro Hoberman; Other
Eligibility: 6 Months to 23 Months
Enrollment: 520 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 2
States / cities: Bardstown, Kentucky • Pittsburgh, Pennsylvania

Conditions: Plantar Fascitis, Fat Pad Syndrome
Interventions: PopSole™ offloading device, padded insole; Device
Lead sponsor: Jeffrey A. Gusenoff, MD; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Liver Cirrhosis, Biliary
Interventions: Obeticholic Acid (OCA), Placebo; Drug
Lead sponsor: Intercept Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 334 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2021
U.S. locations: 43
States / cities: Phoenix, Arizona • Los Angeles, California • Rialto, California + 32 more

Conditions: Hematuria, Urothelial Carcinoma
Interventions: Cxbladder; Diagnostic Test
Lead sponsor: Pacific Edge Limited; Industry
Eligibility: 18 Years and older
Enrollment: 554 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 10
States / cities: Los Angeles, California • Winter Garden, Florida • Chicago, Illinois + 6 more

Conditions: Diabetic Foot Ulcer
Interventions: PEP (Purified Exosome Product) / TISSEEL; Biological
Lead sponsor: Rion Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Blue Ash, Ohio

Conditions: BPD - Bronchopulmonary Dysplasia
Interventions: NAVA technology to synchronize NIPPV; Device
Lead sponsor: New York Medical College; Other
Eligibility: 24 Weeks to 30 Weeks
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Valhalla, New York

Conditions: Wounds and Injury
Interventions: NanoDOX® Hydrogel, CO2 Ablative Fractional Laser; Drug · Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 80 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Scoliosis, Kyphosis, Kyphoscoliosis, Spinal Deformity, Spondylosis
Interventions: Not listed
Lead sponsor: Mazor Robotics; Industry
Eligibility: 21 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Obesity
Interventions: 24-hour energy expenditure and substrate utilization; Other
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 50 Years to 65 Years · Female only
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: Kannapolis, North Carolina

Conditions: Social Anxiety Disorder (SAD)
Interventions: BVR-100, BES-100; Device
Lead sponsor: Sumitomo Pharma America, Inc.; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 6
States / cities: Orlando, Florida • Boston, Massachusetts • Saint Charles, Missouri + 2 more

Conditions: Patient Readmission
Interventions: Post-discharge income supplement, Enhanced care planning; Other
Lead sponsor: AltaMed Health Services Corporation; Other
Eligibility: 55 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Pediatric Cancer, Surgery
Interventions: ARISE with AR, ARISE without AR; Device
Lead sponsor: ALTality, Inc.; Industry
Eligibility: 3 Years to 18 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 2
States / cities: Houston, Texas

Conditions: Abortion Second Trimester
Interventions: Ibuprofen 600 mg, OxyCODONE 5 Mg Oral Tablet; Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older · Female only
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1
Interventions: TI Inhalation Powder and Humalog (Amendment 1), TI Inhalation Powder (original protocol); Drug
Lead sponsor: Mannkind Corporation; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Santa Barbara, California

Conditions: Suicide, Suicide Attempt, Adolescent Suicidality, Suicide Ideation
Interventions: Lock and Protect is a self-administered, web-based decision aid for caregivers of adolescents at risk for suicide.; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 13 Years to 17 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Well-Being, Psychological, Engagement, Satisfaction, Consumer
Interventions: Family Room Application; Device
Lead sponsor: University of Nebraska; Other
Eligibility: 19 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 2
States / cities: Omaha, Nebraska

Conditions: Colorectal Adenocarcinoma, RAS Wild Type, Stage IV Colorectal Cancer AJCC v7, Stage IVA Colorectal Cancer AJCC v7, Stage IVB Colorectal Cancer AJCC v7
Interventions: Bevacizumab, Cetuximab, Irinotecan, Laboratory Biomarker Analysis, Placebo; Biological · Drug · Other
Lead sponsor: Academic and Community Cancer Research United; Other
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 13
States / cities: Scottsdale, Arizona • Boise, Idaho • Sioux City, Iowa + 10 more

Conditions: Cocaine Dependence
Interventions: N-Acetylcysteine, Matching Placebo; Drug
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 65 Years
Enrollment: 111 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2010
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Down Syndrome
Interventions: Down Syndrome Clinic to You (DSC2U); Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 1 Year and older
Enrollment: 281 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Long COVID, Long Coronavirus Disease 2019 (Covid19), Long Covid-19
Interventions: IVIG (intravenous immunoglobulin), IVIG Placebo, Coordinated Care, Usual Care; Drug · Behavioral
Lead sponsor: Kanecia Obie Zimmerman; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Diabetic Polyneuropathy
Interventions: Eptinezumab, Placebo; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 75 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Chemotherapy-induced Peripheral Neuropathy, Nerve Pain, Neuropathy, Neuropathy, Painful, Pain, CIPN - Chemotherapy-Induced Peripheral Neuropathy, Chronic Pain
Interventions: Yoga, Education control, Usual care; Other
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 227 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2028
U.S. locations: 8
States / cities: Boston, Massachusetts • Basking Ridge, New Jersey • Middletown, New Jersey + 5 more

Search by objective public record fields.

CardiAMP™ Cell Therapy for Heart Failure Trial

Novel Endoluminal Clinical TreAtment of Reflux

Efficacy of Short-Course Antimicrobial Treatment for Children With Acute Otitis Media and Impact on Resistance

Offloading Device for Post Surgical Foot Procedures

Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis

STRATA: Safe Testing of Risk for AsymptomaTic MicrohematuriA

Phase 2a Multi-Center Prospective, Randomized Trial to Evaluate the Safety & Efficacy of Topical PEP-TISSEEL for Diabetic Foot Ulcers (DFU)

Randomized Control Trial: Synchronized Non-invasive Positive Pressure Ventilation Versus Non Synchronized Non Invasive Positive Pressure Ventilation in Extremely Low Birth Weight Infants

Investigation of Laser Assisted Drug Delivery of NanoDOX®

ADDRESS - Adult Deformity Robotic vs. Freehand Surgery to Correct Spinal Deformity

Impact of Black Pepper on Energy Expenditure and Substrate Utilization

A Randomized, Controlled Study of Two At-Home Self-Guided Virtual Reality Interventions for Adults With Social Anxiety Disorder.

Effects Of Income Supplements On 30-Day Readmissions For Vulnerable Older Adults

A Pilot Randomized Controlled Trial for Feasibility of Administering an AR Game to Postoperative Pediatric Cancer Patients

Overnight Pain Treatment Investigating Opioids vs. Nonopioids

Safety and Efficacy of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder)When an Optimal Dose is Taken With Varied Carbohydrate Intake

Lock and Protect: Reducing Adolescent Access to Lethal Means of Suicide

The Impact of the Family Room App on Caregivers

Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery

Effectiveness of N-Acetylcysteine (NAC) in Treating Cocaine Dependent Individuals - 1

An Online Health Tool About Down Syndrome: Down Syndrome Clinic to You

RECOVER-AUTONOMIC: Platform Protocol, Appendix A (IVIG)

A Study of CGRP Monoclonal Antibody to Treat Diabetic Neuropathy

The Effect of Yoga on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropathy)